Lysaker, Norway

Thomas Beadnall

This inventor holds 1 USPTO granted patent. Top assignee: Aker Biomarine Human Ingredients as. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Beadnall. Retrieved from https://idiyas.com/inventor/thomas-beadnall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Beadnall: Innovator in Phospholipid Compositions

Introduction

Thomas Beadnall is a notable inventor based in Lysaker, Norway. He has made significant contributions to the field of bioactive compound delivery through his innovative work with phospholipid compositions. His research focuses on enhancing the bioavailability of therapeutic compounds, which has important implications for various health applications.

Latest Patents

Thomas Beadnall holds a patent for "Phospholipid compositions for delivery of therapeutic compounds." This invention relates to compositions that comprise phospholipids designed to deliver bioactive compounds such as ethyl esters, fish oil concentrates, cannabinoids, CoQ10, and curcumin. The unique aspect of this invention is its ability to enhance the bioavailability of these compounds under specific conditions.

Career Highlights

Thomas Beadnall is currently associated with Aker Biomarine Human Ingredients AS. His role in the company allows him to apply his innovative ideas in a practical setting, contributing to advancements in health and nutrition.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Thomas Beadnall's work in phospholipid compositions represents a significant advancement in the delivery of therapeutic compounds. His contributions are poised to impact the health and wellness industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…